Study on Adhesion Properties of Three Different Adhesives
NCT ID: NCT04125797
Last Updated: 2019-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2019-10-07
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigation centre will enroll 39 subjects including a 20% drop out within a four (4) months period. The subject will not be enrolled before approval of investigation protocol by the local ethics committee.
The subjects need to meet the inclusion and exclusion criteria to be included in this clinical investigation. Each volunteer enrolled in the investigation can only participate once in a procedure. The testing period for each subject will be minimum 72 hours.
The principal investigator's qualifications will be verified through his/her CV. The principal investigator is required to be a medical doctor with at least one year's experience in using similar medical adhesives (e.g. by being experienced in using electrodes where medical adhesives are included) and at least one year's experience with clinical research. In addition, the investigator must be trained in GCP before the study is initiated.
If any subject withdraws from the study, they will not be replaced as drop-out rate is included in the sample size.
Subjects must show up for two sessions, in the first session six adhesives will be placed below the subjects bra. The adhesives will be removed after minimum 72 hours at the second visit. While wearing the adhesives the subjects must keep the investigational area dry. 24, 48 and 72 hours after placement of the adhesives, the subject is asked to completed a questionnaire.
The eCRF must be completed for each subject that has signed the Informed consent form (ICF) and enrolled into this clinical investigation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Wound Care Product Skin Adhesion
NCT07136870
A Study to Assess Wound Healing Efficacies of Different Adhesive Bandages
NCT04040933
Gellan Contact Study
NCT04044014
Post Approval Study to Evaluate the Safety and Performance of GENTA-FOIL Resorb® in Hand Surgery
NCT04482140
Evaluating the Use of a Concentrated Surfactant Gel in Burn Patients
NCT04084093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adhesive 1
This arm investigates one type of silicone adhesive (3M2475P) on adult female skin.
Application of adhesive
Adhesive will be placed on the subjects skin below the bra. Placement of the adhesive will be randomized.
Adhesive 2
This arm investigates one type of silicone adhesive (RX1449P) on adult female skin.
Application of adhesive
Adhesive will be placed on the subjects skin below the bra. Placement of the adhesive will be randomized.
Adhesive 3
This arm investigates one type of silicone adhesive (PS-1243) on adult female skin.
Application of adhesive
Adhesive will be placed on the subjects skin below the bra. Placement of the adhesive will be randomized.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Application of adhesive
Adhesive will be placed on the subjects skin below the bra. Placement of the adhesive will be randomized.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 - 40 years old.
* Willing to attend two scheduled visits
* Able to assess itch and adherence at 24h, 48h and 72h.
* Provide written informed consent.
Exclusion Criteria
* History of inflammatory skin diseases (e.g. atopic dermatitis or psoriasis).
* History of contact allergy
* Swimming or engaging in sport activities causing sweat during study peri-od. v. Use of medication (e.g. corticosteroids) which could affect skin reactions.
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ambu A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gentofte Hospital
Hellerup, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIS-015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.